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Allosterya b s t r a c t
This article sketches the road from the establishment of the principles of enzyme kinetics, at the
beginning of the 20th century, to the discovery of regulatory mechanisms and the models to explain
them, from the middle of the century onwards. A long gap in time separates the two periods, in
which technological advances were made that allowed the discovery of feedback inhibition and
cooperativity. In particular, these discoveries and the theory needed to explain them could not have
been made without knowledge of the major metabolic pathways and the enzymes and metabolites
involved in them.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
This year marks not only the centenary of the Michaelis–Men-
ten equation, published in Biochemische Zeitschrift [1], but also
the half-centenary of the allosteric concept proposed by Monod,
Changeux and Jacob in the Journal of Molecular Biology [2] that
opened the way for understanding cooperativity and feedback
inhibition. As we will see (Fig. 1), a long road separates the two
events, as the ﬁrst reports of feedback effects did not appear until
several decades after Michaelis and Menten.
Leonor Michaelis’s contribution to enzyme kinetics is enor-
mous, in particular his work with Maud Menten [1], and their arti-
cle can be considered an inﬂection point in the curve of the
development of the ﬁeld. In the 19th century researchers had stud-
ied chemical reactions that in general proceeded in a single step, so
that following the course of reaction presented no great problem.
However, when the study of enzyme reactions started, although
the idea of the formation of an enzyme–substrate complex already
existed [3,4], people continued trying to analyse the kinetics in
terms of the progress curve of the reaction, until Michaelis and
Menten drew attention to a better strategy. They not only used cor-
rect algebra for analysing their data, but also emphasized two
important points, the advantages of working in conditions of initial
velocity and the necessity of controlling the pH (the pH scalehaving been introduced a little earlier [5]). If these conditions were
satisﬁed the curve of velocity in function of the concentration of
substrate needed to be a hyperbola, deﬁned by two parameters,
what we now call the Michaelis constant, Km, and the maximal
velocity V (or, more appropriately, the limiting velocity) [6]. The
reanalysis of Michaelis and Menten’s results in terms of the
steady-state interpretation [7] did not alter the fundamental
correctness of their approach.
This realization and the establishment of a correct experimental
protocol were crucial, because they meant that any deviation from
hyperbolic behaviour needed an explanation. The possibility of
recognizing deviations allowed enzyme cooperativity to be discov-
ered, and models were developed to explain it. These deviations
from hyperbolic behaviour were initially received with surprise
and worry, as it was not easy to show that they were not artefacts.
Umbarger [8], for example, referred to ‘peculiar kinetic behavior’
and Gerhart and Pardee, although several years later, still talked
about ‘complex kinetics’ [9]. By that time, of course, the coopera-
tive binding of oxygen to haemoglobin was well known [10,11]
and was a source of inspiration for the development of models that
could explain the peculiar kinetic behaviour. It may appear surpris-
ing, however, that it took so long, more than 40 years from the time
of Michaelis and Menten, to recognize the ﬁrst cases of deviation
from hyperbolic kinetics; in fact it is not so surprising, as discussed
below, because to detect a deviation an adequate range of
substrate concentrations must be studied and the velocity pre-
Fig. 1. Chronology of the main steps from establishing the principal kinetic characteristics of enzyme-catalyzed reactions (1902–1925) to the discovery and analysis of
regulatory mechanisms (from 1956). The long gap between Michaelis and Menten (1913) on the one hand and Umbarger (1956) and Yates and Pardee (1956) on the other
corresponds to the period in which the major metabolic pathways were elucidated, and the metabolites and enzymes involved in them characterized.
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feedback inhibition show cooperativity, so the number of possible
examples was not large.
2. Practical problems for obtaining adequate saturation curves
The necessity of working in conditions of initial velocity [1] not
only showed how to do kinetic experiments well, but it also im-
posed a very signiﬁcant constraint on kinetic studies, because it
implied a capacity to detect small amounts of product with sufﬁ-
cient accuracy, or small decreases in substrate concentration, and
at that time this was not easy. In practice it required analytical
methods sensitive enough to cope with this restriction. Further-
more, as the initial velocity is a measure of the tangent to the pro-
gress curve at time zero, which requires a curve with a sufﬁcient
number of points, the ideal situation is to use an analytical method
whose results could be registered continuously, such as a spectro-
photometric test. Nowadays, this is no problem, as any laboratory
has such equipment, but that was not the case at the time of
Michaelis, nor for a considerable time afterwards. Furthermore,
even when people started to have spectrophotometers, many reac-
tions could not be followed directly, as they produced no observa-
ble spectrophotometric change. The realization that coupled assays
could be used [12–14], where, for example, the oxidation of
NAD(P)H or the reduction of NAD(P) could be followed, was an
important step in the right direction. Much later, the development
of the theory of coupled assays [15–17] allowed a reliable protocol
to be established, and this provided a powerful tool for studying
enzyme kinetics and contributed strongly to the ﬁeld.
A deviation from hyperbolic behaviour does not necessarily
mean, however, the existence of cooperativity. Enzymes are often
unstable, and they can become inactivated in the assay conditions,
and as substrates usually act as stabilizing factors, an increase in
substrate concentration may produce increases in product forma-
tion, above what the Michaelis–Menten equation would predict.
In such a case the curve of rate as a function of substrate concen-
tration may appear sigmoidal instead of hyperbolic. The problem
of enzyme instability is serious, and it was especially so during
the ﬁrst half of the 20th century when there was not enough
knowledge about how to stabilize enzymes. It is not surprisingthen, that many of the studies were done with enzymes chosen
for their stability, such as extracellular enzymes, usually studied
with artiﬁcial substrates. As a matter of fact, both Henri [4] and
Michaelis and Menten [1] made their pioneering kinetic studies
with invertase, an extracellular enzyme secreted by yeast.
(Although invertase is little studied in modern biochemistry, it is
widely used in the confectionary industry for production of choco-
lates with liquid centres.)
Extracellular enzymes have also the advantage that they have
fewer ‘contaminants’ than intracellular ones and tend to be easier
to purify. Obtaining pure enzymes and even partially puriﬁed ones
was a difﬁcult task, and progress required knowledge of how to
stabilize enzymes, and the development of puriﬁcation techniques
and of such appropriate materials as ion-exchange resins and ﬁl-
tration gels. Afﬁnity chromatography, which contributed greatly
to the ﬁeld, only developed in the 1970s.
Something crucial to bear in mind is that at the time of Michae-
lis and Menten, and for several decades afterwards, metabolic
pathways and intermediates had not been well established, and
the corresponding enzymes were also not well known: for exam-
ple, the Krebs cycle was not proposed until 1937 [18], and re-
mained controversial for a considerable time afterwards, with
some of the enzymes, such as isocitrate dehydrogenase [19] still
needing to be characterized. Many studies were done using crude
tissue extracts. Only when knowledge of protein chemistry had ad-
vanced sufﬁciently could the study of intracellular enzymes be
accomplished with the use of natural substrates, which were in
many cases metabolites, and the phenomena of cooperativity and
allostery could be revealed.
An artefactual deviation from hyperbolic behaviour could also
be attributed to problems of controlling the concentration of the
real substrate. This could happen if, for example, the real substrate
was a complex with a metal ion, and the variation of substrate con-
centration had failed to take this into account. A good example is
ATP, for the real substrate is nearly always MgATP.
Furthermore, in order to clearly detect a deviation from the ex-
pected hyperbolic behaviour it is necessary to make measurements
at several substrate concentrations, both above and below half-sat-
uration. At the lower concentrations the problems of enzyme insta-
bility just mentioned and of lacking an adequate detecting method
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few observations at these low concentrations.
For all these reasons it is not surprising that several decades
passed after the pioneering work of Michaelis and Menten before
the ﬁrst cases of deviation from the expected behaviour were re-
ported [8,9]. Probably such deviations had been observed before,
but experimenters lacked the conﬁdence to report them, and re-
garded them as artefacts.
3. Feedback inhibition and cooperativity: two faces of the same
coin
Among the ﬁrst enzyme reactions known not to follow the clas-
sical hyperbolic behaviour were threonine deaminase [8] and
aspartate transcarbamoylase [9], and such enzymes also showed
feedback inhibition. In other words cooperativity and feedback
inhibition were discovered at the same time.
During the 1950s there was great interest in cybernetics, the
study of control systems originated by Wiener [20] and still with
some inﬂuence today [21]. There were indications that feedback
control could exist in living organisms: for example, in Escherichia
coli the presence of isoleucine in the culture medium prevented
threonine from being metabolized to isoleucine [22]. In 1956
Umbarger shed light on this phenomenon in a classic paper of a
single page in Science [8]. He studied the effect of isoleucine on
deamination of threonine, the ﬁrst step in the conversion of threo-
nine to isoleucine, and found that isoleucine was a very strong
inhibitor, 100 times stronger than leucine. Surprisingly, in spite
of the structural difference with the substrate, the inhibition was
competitive. Furthermore, the kinetic results were ‘peculiar’, be-
cause to obtain a straight line in the double-reciprocal plot he
needed to use the square of the substrate concentration. So, to-
gether with ﬁnding the existence of deviations from the expected
hyperbolic behaviour he found evidence of a negative feedback.
Umbarger’s observation on threonine deaminase was very
important, as it is one of the ﬁrst cases of deviation from the ex-
pected hyperbolic kinetic behaviour to be reported. However, as
this could have been an artefact, for the reasons mentioned earlier,
he added: ‘Further experiments are in progress in an effort to de-
cide whether this peculiar kinetic behavior is apparent or real.’
These results were conﬁrmed later [23], but they continued to be
worried. In relation to their Fig. 5 the authors said: ‘It is to be noted
that the abscissa is 1/S2 rather than the usual 1/S since this reaction
appears to be bimolecular with respect to both substrate and
inhibitor. Attempts to alter the conditions of assaying enzyme
activity so as to obtain the usual monomolecular kinetic behavior
have been unsuccessful.’ [23].
Umbarger’s observations [8,23] were later conﬁrmed by Jean-
Pierre Changeux during his thesis work [24] using a derepressed
mutant which produced more than ten times more enzyme than
the wild type. Like Umbarger, he found that the kinetics of L-thre-
onine deamination, both in the absence and presence of L-isoleu-
cine, were ‘somewhat complex’ and ‘does not follow simple
Michaelis–Menten kinetics’. Furthermore, he found that the inhib-
itory effect of isoleucine was competitive with respect to threo-
nine, even with puriﬁed enzyme (Umbarger’s experiments were
done with crude extracts). The complexity of the kinetics induced
him to postulate that distinct binding groups would exist on the
surface of the enzyme, and that consequently it would be possible
to desensitize the enzyme, that is to have a threonine deaminase
still active but insensitive to isoleucine. p-Chloromercuribenzoate
proved to be very effective for achieving this, indicating that par-
tially different groups are involved in the binding of threonine
and isoleucine in spite of the competitive character of the inhibi-
tion. So here are the roots that would lead to the concept of the
allosteric site [2]. Another concept that also emerges from the workof Changeux and his observation of the deviation of Michaelis–
Menten kinetics is the idea of a threshold, very important in meta-
bolic regulation. Thus he said ‘it is worth noting that as a result of
the ‘‘bimolecular’’ kinetics of inhibition the effect of metabolite
becomes signiﬁcant above a threshold value. In other words, the
intracellularmetabolic pool shouldbecomeeffective in the feedback
system only when the concentration rises above a critical level’.
Another early case of feedback inhibition was the control of
pyrimidine biosynthesis in E. coli by cytosine derivatives: these in-
hibit formation in vivo of the pyrimidine intermediate ureidosuc-
cinic acid [25], now known as carbamoylaspartate. Experiments
in vitro with crude extracts showed that cytidine, and especially
cytidine-5-phosphate, acted as competitive inhibitors with respect
to aspartate for the formation of ureidosuccinic acid, the ﬁrst reac-
tion unique to pyrimidine biosynthesis [25]. Thus a nucleotide end
product was able to compete with a structurally very different sub-
strate, an aminoacid. As these experiments, like Umbarger’s, were
done in crude extracts one could argue that the inhibition by cyto-
sine derivatives could be indirect: for example, these derivatives
could have been transformed in the extract to the real inhibitor.
Afterwards aspartate transcarbamoylase, the enzyme responsible
for forming carbamoylaspartate, was puriﬁed and the experiments
repeated with a highly puriﬁed enzyme [9]. Gerhart and Pardee
conﬁrmed that CTP inhibits competitively with respect to aspartate
[9]. Furthermore, CTP appeared to bind to a second site different
from the active site, which they called the feedback site, as the en-
zyme could be desensitized without losing catalytic activity [9].
This led them to postulate that ‘the bound end product perhaps
inhibits by deforming the enzyme so that the latter has a low afﬁn-
ity for the substrate’. This beautiful classic paper, which had great
inﬂuence on my own research (see below), gives a very good illus-
tration of what Monod, Changeux and Jacob would call an allosteric
site [2]; it also describes an activator, ATP. However, something
that I ﬁnd very puzzling is that although the deviation from hyper-
bolic behaviour leaps out at the modern reader’s eye, with signiﬁ-
cant and very noticeable cooperativity with respect to aspartate in
Figs. 2, 3 and 5 of that paper, they downplayed this observation: in
relation to their Fig. 2 they only said ‘Despite the complex kinet-
ics. . .’, adding in a footnote that ‘Further kinetic studies and possi-
ble explanations for their anomalous appearance may be found in
the thesis of J. C. Gerhart, University of California, 1962’. In relation
to the desensitized enzyme (their Fig. 3) they just said that ‘the
dependence of velocity on aspartate concentration followed a
curve unlike the unusual sigmoidal dependence of the native en-
zyme’. This lack of emphasis on the cooperativity may perhaps
be because they did not have any explanation for it, whereas they
did have a plausible mechanism for explaining the feedback inhibi-
tion. As late as 1962, therefore, the observation of sigmoidal
dependence was seen with some suspicion, as it went against the
ideas established in the article of Michaelis and Menten, despite
the fact that the cooperativity of oxygen binding to haemoglobin
had been known since 1910 [10,11]. It is a great pity that they
did not pay more attention to the sigmoidicity because their article
also illustrates very clearly the idea that effectors modify the de-
gree of cooperativity with respect to the substrate, inhibitors by
increasing it and activators by decreasing it: CTP (inhibitor) in-
creased cooperativity with respect to aspartate (their Fig. 2)
whereas ATP (activator) decreased it (their Fig. 5).
Once the ﬁrst cases of deviation from the hyperbolic behaviour
were conﬁrmed (sigmoidal dependence of velocity as a function of
substrate concentration), others were reported, and the 1960s and
1970s produced several examples. Enzyme cooperativity was thus
discovered simultaneously with feedback inhibition, and the driv-
ing force was the desire to understand feedback mechanisms,
which appeared to have a clear physiological importance. It was
therefore not by chance that both properties were discovered at
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molecular explanations. It is quite probable that what evolution se-
lected was feedback inhibition of enzymes involved in pathways con-
trolled by demand, with substrate cooperativity being a side effect, as
suggested byHofmeyr andCornish-Bowden [26]. In fact, substrate sig-
moidicity is often small, but it is increased and can even be induced by
an allosteric inhibitor [27], whereas feedback inhibition (i.e. allosteric
inhibition) does tend to be cooperative, probably to allow the
possibility of a threshold in the response to demand.
4. Models to explain cooperativity and allostery
Models were then derived to explain the observed sigmoidicity
and the effects of inhibitors that were structurally unlike the sub-
strates, i.e. allostery. As new ideas do not come out of the blue, but
arise in a deﬁnite context, it is not surprising that the ﬁrst models
were based on binding: that is, the cooperative binding of sub-
strates, inhibitors or activators. The importance of haemoglobin
in the development of these ideas is great: not for nothing is it
called an ‘honorary enzyme’. At the time when models were devel-
oped little was known about the quaternary structure of enzymes
with cooperativity. One of the few X-ray structures available was
that of haemoglobin [28]. Structures of allosteric enzymes such
as aspartate carbamoyltransferase came much later [29].
Two principal models appeared in the mid-1960s to explain
cooperativity and allostery: the allosteric model, also called the
symmetry model or the concerted model, proposed by Monod et al.
[30], and the sequential model proposed by Koshland, Némethy
and Filmer a year later [31]. Both attach a functional importance
to multiple conformations, an idea that originated with Koshland’s
induced ﬁt hypothesis [32].
A central feature of the allosteric model is conformational reg-
ulation. Thus, an equilibrium exists between two conformational
states, usually known as the R (‘relaxed’) and T (‘tense’) states, in
the absence of any ligand. Different ligands bind preferentially to
one of the two states, and thus perturb the equilibrium between
them. Furthermore, all of the subunits in an oligomeric protein
change between the R and T states in a concerted manner, so sym-
metry is maintained.
In contrast, the sequential model did not require conforma-
tional symmetry, as the conformational change of each subunit oc-
curs only when ligand is bound. Thus in this case it is the ligand
that induces the conformational change. In the absence of ligand
there is a different conformation.
As both models explained the observed kinetic cooperativity on
the basis of cooperativity of substrate binding, this implied that the
enzyme should be oligomeric, or there must be more than one ac-
tive site per enzyme molecule. However, as there is usually only
one active site per monomer, with rare exceptions such as verte-
brate hexokinase B or II [33,34], this meant that monomeric en-
zymes should not be cooperative: they could show allostery, but
not cooperativity.
This limitation encouraged some people in the 1960s, such as Ra-
bin [35], to seek models that could explain kinetic cooperativity
without needing cooperative binding: this could be based, for exam-
ple, on enzyme isomerization during the course of the reaction [35].
This was initially a sort of intellectual challenge as no monomeric
enzymes showing deviations from hyperbolic behaviour had been
described experimentally, at least, none with natural substrates.
5. Glucokinase: a monomeric enzyme with cooperativity, but no
feedback inhibition
In 1975 this view changed after Hermann Niemeyer and col-
leagues in Chile described sigmoidal kinetics for ‘glucokinase’ (i.e.
hexokinase D or hexokinase IV) [36], the enzyme responsible forglucose phosphorylation in hepatocytes, whose activity level in
liver depends on diet and hormonal regulation [37]. This glucose
uptake is an essential physiological process, crucial for glucose
homeostasis. It has acquired greatly increased interest and impor-
tance with the rise in recent decades of diabetes type 2 as a major
problem of human health [38,39] (the name ‘glucokinase’ is almost
universal in the literature, so I shall use it here, but it gives a
misleading impression of the speciﬁcity [37,40]).
The ﬁrst kinetic studies on glucokinase did not report this sig-
moidal behaviour because of the difﬁculties referred to above: pre-
vious studies from various groups had too few observations, and so
although the possibility of deviations from hyperbolic behaviour
was in the air, it was far from being clear [41,42]. When I joined
Niemeyer’s group and started to work with this enzyme, my night-
mare was that the apparent positive cooperativity that I was
observing could be an artefact, especially because the degree of
cooperativity was rather small, with a Hill coefﬁcient of about
1.5, and the enzyme rather unstable. So the paper of 1975 [36] de-
scribed several experiments that were intended to convince our-
selves that the apparent cooperativity was real, as the enzyme
appeared to be a monomer (the form of enzyme with a higher
molecular mass mentioned in that paper may have been a complex
of glucokinase with the regulatory protein, discovered several
years afterwards [43]). The fact that the liver glucokinase obtained
from different mammalian species, and also from reptiles and
amphibians, had a similar degree of cooperativity, despite signiﬁ-
cant variations in the half-saturation values, tended to support
the idea that the cooperativity was not an artefact, and could have
a physiological value. It was a relief, therefore, that a year later a
group in England described a similar degree of cooperativity [44],
this time with the pure enzyme, and showed that it was a mono-
mer [45]. Of course, the crucial question from the point of view
of a plausible cooperative mechanism was the quaternary struc-
ture in the assay conditions: it also proved to be monomeric [46].
Glucokinase was thus the ﬁrst monomeric enzyme with sigmoi-
dal kinetics. Inﬂuenced by the work of Gerhart and Pardee [9] I
tried to ‘desensitize’ it, thinking that it could have an allosteric site
capable of binding glucose. All the efforts were in vain, as there is
no such site: as long as the enzyme retained activity it continued to
show sigmoidicity. In the absence of interacting sites positive
cooperativity requires a kinetic mechanism in which binding of
substrates is not at equilibrium in the steady state; it can only be
a kinetic property that cannot occur at thermodynamic equilib-
rium. Two models were postulated at the time for explaining the
cooperativity: the mnemonical model [47,48] and the slow-transi-
tion model [49,50], as we have reviewed [51]. Brieﬂy, in both mod-
els the enzyme exists in two distinct forms, E and E’ that are
interconverted relatively slowly, with the more stable form E’ pre-
dominating in the absence of glucose. In the mnemonical model
the less stable form E is the one released at the end of the catalytic
cycle. The slow-transition model is somewhat more complicated,
as both conformations can accomplish a catalytic cycle, but with
different kinetic parameters. In both models, as glucose binds in
two different steps, the full rate equation contains terms in the
squared concentration of glucose, thereby allowing deviations
from Michaelis–Menten kinetics.
Besides being monomeric and showing cooperativity, glucoki-
nase is unusual in that it does not show feedback inhibition. As it
is an enzyme controlled by supply [52,53] and not by demand, evo-
lution appears not to have selected a feedback mechanism, whose
function in demand-driven pathways is to displace the control
from the ﬁrst enzyme to the demand for the end-product [54],
and is crucial for maintaining homeostasis of intermediates. This
lack of feedback appears to have dramatic consequences for human
health, because drugs that activate it, which were seen as potential
medicines for diabetes, as they are effective for decreasing
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long term [55], probably because there is no feedback that controls
the system.
6. Forty years in the wilderness
The large gap in time visible in Fig. 1 is at ﬁrst sight surpris-
ing: why did it take so long for regulatory mechanisms to be
discovered? This gap, however, corresponds to the period in
which metabolic pathways were being elucidated, intermediates
being identiﬁed, methods for purifying and stabilizing proteins
being developed, as well as methods for following the progress
curves of the reactions with high sensitivity. This period of about
40 years after Michaelis and Menten — 40 years in the wilderness
— illustrates very well that progress in science has two require-
ments, not only a guiding vision, but also an adequate technology.
As Woese [56] commented in relation to the biology of the 21st
century, but it applies equally well to the early development of
enzymology in the 20th, ‘without an adequate technological
advance the pathway of progress is blocked, and without an
adequate guiding vision there is no pathway, there is no way
ahead’.
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